Notch as a tumour suppressor (original) (raw)

• Wilson, A. & Radtke, F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett. 580, 2860–2868 (2006).
  Article CAS PubMed Google Scholar
• Liu, J., Sato, C., Cerletti, M. & Wagers, A. Notch signaling in the regulation of stem cell self-renewal and differentiation. Curr. Top. Dev. Biol. 92, 367–409 (2010).
  Article CAS PubMed Google Scholar
• Koch, U. & Radtke, F. Notch and cancer: a double-edged sword. Cell. Mol. Life Sci. 64, 2746–2762 (2007).
  Article CAS PubMed Google Scholar
• Radtke, F. & Raj, K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat. Rev. Cancer 3, 756–767 (2003).
  Article CAS PubMed Google Scholar
• Koch, U. & Radtke, F. Notch in T-ALL: new players in a complex disease. Trends Immunol. 32, 434–442 (2011).
  Article CAS PubMed Google Scholar
• Koch, U. & Radtke, F. Mechanisms of T cell development and transformation. Annu. Rev. Cell Dev. Biol. 27, 539–562 (2011).
  Article CAS PubMed Google Scholar
• Teodorczyk, M. & Schmidt, M. H. Notching on cancer's door: Notch signaling in brain tumors. Front. Oncol. 4, 341 (2014).
  PubMed Google Scholar
• Reedijk, M. Notch signaling and breast cancer. Adv. Exp. Med. Biol. 727, 241–257 (2012).
  Article CAS PubMed Google Scholar
• McAuliffe, S. M. et al. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc. Natl Acad. Sci. USA 109, E2939–E2948 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Galluzzo, P. & Bocchetta, M. Notch signaling in lung cancer. Expert Rev. Anticancer Ther. 11, 533–540 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Andersson, E. R., Sandberg, R. & Lendahl, U. Notch signaling: simplicity in design, versatility in function. Development 138, 3593–3612 (2011).
  Article CAS PubMed Google Scholar
• Logeat, F. et al. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl Acad. Sci. USA 95, 8108–8112 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Gordon, W. R. et al. Structural basis for autoinhibition of Notch. Nat. Struct. Mol. Biol. 14, 295–300 (2007).
  Article PubMed CAS Google Scholar
• Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216–233 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Dunwoodie, S. L., Henrique, D., Harrison, S. M. & Beddington, R. S. Mouse Dll3: a novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo. Development 124, 3065–3076 (1997).
  CAS PubMed Google Scholar
• Ladi, E. et al. The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands. J. Cell Biol. 170, 983–992 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Bozkulak, E. C. & Weinmaster, G. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol. Cell. Biol. 29, 5679–5695 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Fortini, M. E. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat. Rev. Mol. Cell Biol. 3, 673–684 (2002).
  Article CAS PubMed Google Scholar
• Gordon, W. R. et al. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood 113, 4381–4390 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Baron, M. Endocytic routes to Notch activation. Semin. Cell Dev. Biol. 23, 437–442 (2012).
  Article CAS PubMed Google Scholar
• Hori, K., Sen, A., Kirchhausen, T. & Artavanis-Tsakonas, S. Regulation of ligand-independent Notch signal through intracellular trafficking. Commun. Integr. Biol. 5, 374–376 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Palmer, W. H. & Deng, W. M. Ligand-independent mechanisms of Notch activity. Trends Cell Biol. 25, 697–707 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Bray, S. J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7, 678–679 (2006).
  Article CAS PubMed Google Scholar
• Ishibashi, M. Molecular mechanisms for morphogenesis of the central nervous system in mammals. Anat. Sci. Int. 79, 226–234 (2004).
  Article CAS PubMed Google Scholar
• Holmberg, J. et al. SoxB1 transcription factors and Notch signaling use distinct mechanisms to regulate proneural gene function and neural progenitor differentiation. Development 135, 1843–1851 (2008).
  Article CAS PubMed Google Scholar
• Koch, U., Lehal, R. & Radtke, F. Stem cells living with a Notch. Development 140, 689–704 (2013).
  Article CAS PubMed Google Scholar
• Radtke, F. et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547–558 (1999).
  Article CAS PubMed Google Scholar
• Riccio, O. et al. Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. EMBO Rep. 9, 377–383 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Pellegrinet, L. et al. Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Gastroenterology 140, 1230–1240 (2011).
  Article PubMed CAS Google Scholar
• Blanpain, C. & Fuchs, E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat. Rev. Mol. Cell Biol. 10, 207–217 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154–1157 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157–1160 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Pickering, C. R. et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin. Cancer Res. 20, 6582–6592 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• South, A. P. et al. NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis. J. Invest. Dermatol. 134, 2630–2638 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Wang, N. J. et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc. Natl Acad. Sci. USA 108, 17761–17766 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Rampias, T. et al. A new tumor suppressor role for the Notch pathway in bladder cancer. Nat. Med. 20, 1199–1205 (2014).
  Article CAS PubMed Google Scholar
• Gao, Y. B. et al. Genetic landscape of esophageal squamous cell carcinoma. Nat. Genet. 46, 1097–1102 (2014).
  Article CAS PubMed Google Scholar
• Song, Y. et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature 509, 91–95 (2014).
  Article CAS PubMed Google Scholar
• The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315–322 (2014).
• Pickering, C. R. et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 3, 770–781 (2013).
  Article CAS PubMed Google Scholar
• Abel, E. L., Angel, J. M., Kiguchi, K. & DiGiovanni, J. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc. 4, 1350–1362 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Nassar, D., Latil, M., Boeckx, B., Lambrechts, D. & Blanpain, C. Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma. Nat. Med. 21, 946–954 (2015). This study provided a comprehensive analysis of the genomic aberrations that occur in genetic and chemically induced mouse SCC.
  Article CAS PubMed Google Scholar
• Nicolas, M. et al. Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet. 33, 416–421 (2003). This work provided the first functional in vivo evidence that NOTCH1 functions as a tumour suppressor in non-melanoma skin cancer.
  Article CAS PubMed Google Scholar
• Extance, A. Alzheimer's failure raises questions about disease-modifying strategies. Nat. Rev. Drug Discov. 9, 749–751 (2010).
  Article CAS PubMed Google Scholar
• Maraver, A. et al. NOTCH pathway inactivation promotes bladder cancer progression. J. Clin. Invest. 125, 824–830 (2015). This study presented in vivo functional evidence that Notch signalling functions as a tumour suppressor in the bladder.
  Article PubMed PubMed Central Google Scholar
• Alcolea, M. P. et al. Differentiation imbalance in single oesophageal progenitor cells causes clonal immortalization and field change. Nat. Cell Biol. 16, 615–622 (2014). This work demonstrated how impaired Notch signalling in oesophageal epithelial progenitor cells could result in perturbed differentiation promoting 'field change' in the oesophagus.
  Article PubMed PubMed Central CAS Google Scholar
• Zeng, Q. et al. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8, 13–23 (2005).
  Article CAS PubMed Google Scholar
• Gokulan, R. & Halagowder, D. Expression pattern of Notch intracellular domain (NICD) and Hes-1 in preneoplastic and neoplastic human oral squamous epithelium: their correlation with c-Myc, clinicopathological factors and prognosis in oral cancer. Med. Oncol. 31, 126 (2014).
  Article CAS PubMed Google Scholar
• Yoshida, R. et al. The pathological significance of Notch1 in oral squamous cell carcinoma. Lab. Invest. 93, 1068–1081 (2013).
  Article CAS PubMed Google Scholar
• Zhao, Z. L. et al. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell. Sci. Rep. 6, 24704 (2016).
  Article PubMed PubMed Central CAS Google Scholar
• Hijioka, H. et al. Upregulation of Notch pathway molecules in oral squamous cell carcinoma. Int. J. Oncol. 36, 817–822 (2010).
  CAS PubMed Google Scholar
• Yao, J., Duan, L., Fan, M. & Wu, X. Gamma-secretase inhibitors exerts antitumor activity via down-regulation of Notch and nuclear factor kappa B in human tongue carcinoma cells. Oral Dis. 13, 555–563 (2007).
  Article CAS PubMed Google Scholar
• George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47–53 (2015). This paper identified loss-of-function mutations in Notch family members in SCLC and provided in vivo evidence of a tumour-suppressor role of Notch signalling using a mouse model.
  Article PubMed PubMed Central CAS Google Scholar
• Viatour, P. et al. Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. J. Exp. Med. 208, 1963–1976 (2011). This study demonstrated that the use of a GSI to inhibit Notch signalling in a mouse model of HCC resulted in impaired tumour development.
  Article PubMed PubMed Central CAS Google Scholar
• Kawaguchi, K. et al. Jagged1 DNA copy number variation is associated with poor outcome in liver cancer. Am. J. Pathol. 186, 2055–2067 (2016).
  Article CAS PubMed Google Scholar
• Ma, L. et al. Overexpression of protein _O_-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway. Biochem. Biophys. Res. Commun. 473, 503–510 (2016).
  Article CAS PubMed Google Scholar
• Giachino, C. et al. A tumor suppressor function for Notch signaling in forebrain tumor subtypes. Cancer Cell 28, 730–742 (2015). This study used a mouse model of glioma to functionally demonstrate for the first time in vivo that Notch signalling functions as a tumour suppressor in forebrain tumours.
  Article CAS PubMed Google Scholar
• Alcantara Llaguno, S. et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15, 45–56 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396–401 (2004).
  Article CAS PubMed Google Scholar
• Brat, D. J. et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481–2498 (2015).
  Article CAS PubMed Google Scholar
• Suzuki, H. et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat. Genet. 47, 458–468 (2015).
  Article CAS PubMed Google Scholar
• Fan, X. et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28, 5–16 (2010).
  PubMed PubMed Central CAS Google Scholar
• Purow, B. W. et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res. 65, 2353–2363 (2005).
  Article CAS PubMed Google Scholar
• Wang, J. et al. Notch promotes radioresistance of glioma stem cells. Stem Cells 28, 17–28 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Xu, P. et al. The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo. J. Neurooncol. 97, 41–51 (2010).
  Article CAS PubMed Google Scholar
• Krop, I. et al. Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J. Clin. Oncol. 30, 2307–2313 (2012).
  Article CAS PubMed Google Scholar
• Schonberg, D. L., Lubelski, D., Miller, T. E. & Rich, J. N. Brain tumor stem cells: molecular characteristics and their impact on therapy. Mol. Aspects Med. 39, 82–101 (2014).
  Article CAS PubMed Google Scholar
• Crabtree, J. S., Singleton, C. S. & Miele, L. Notch signaling in neuroendocrine tumors. Front. Oncol. 6, 94 (2016).
  Article PubMed PubMed Central Google Scholar
• Kunnimalaiyaan, M., Vaccaro, A. M., Ndiaye, M. A. & Chen, H. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. J. Biol. Chem. 281, 39819–39830 (2006).
  Article CAS PubMed Google Scholar
• Kunnimalaiyaan, M., Yan, S., Wong, F., Zhang, Y. W. & Chen, H. Hairy enhancer of split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells. Surgery 138, 1137–1142 (2005).
  Article PubMed Google Scholar
• Nakakura, E. K. et al. Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. J. Clin. Endocrinol. Metab. 90, 4350–4356 (2005).
  Article CAS PubMed Google Scholar
• Rekhtman, N. et al. Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets. Clin. Cancer Res. 22, 3618–3629 (2016).
  Article PubMed PubMed Central CAS Google Scholar
• Maitra, A. & Hruban, R. H. Pancreatic cancer. Annu. Rev. Pathol. 3, 157–188 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Almoguera, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549–554 (1988).
  Article CAS PubMed Google Scholar
• Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437–450 (2003).
  Article CAS PubMed Google Scholar
• De La O, J.-P. et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc. Natl Acad. Sci. USA 105, 18907–18912 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Miyamoto, Y. et al. Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3, 565–576 (2003).
  Article CAS PubMed Google Scholar
• Mazur, P. K. et al. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Proc. Natl Acad. Sci. USA 107, 13438–13443 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Plentz, R. et al. Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology 136, 1741–1749 (2009).
  Article PubMed CAS Google Scholar
• Maniati, E. et al. Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Ppargamma expression and promotes pancreatic cancer progression in mice. J. Clin. Invest. 121, 4685–4699 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Cook, N. et al. Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma. J. Exp. Med. 209, 437–444 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Hanlon, L. et al. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res. 70, 4280–4286 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Oncomed. Oncomed provides update on tarextumab phase 2 pancreatic cancer ALPINE trial. GlobeNewswire https://globenewswire.com/news-release/2016/01/25/804294/0/en/OncoMed-Provides-Update-on-Tarextumab-Phase-2-Pancreatic-Cancer-ALPINE-Trial.html (2016).
• Nakhai, H. et al. Conditional ablation of Notch signaling in pancreatic development. Development 135, 2757–2765 (2008).
  Article CAS PubMed Google Scholar
• Avila, J. L. & Kissil, J. L. Notch signaling in pancreatic cancer: oncogene or tumor suppressor? Trends Mol. Med. 19, 320–327 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Bilous, N. I., Abramenko, I. V., Chumak, A. A., Dyagil, I. S. & Martina, Z. V. Detection of NOTCH1 c.7541_7542delCT mutation in chronic lymphocytic leukemia using conventional and real-time polymerase chain reaction. Exp. Oncol. 38, 112–116 (2016).
  Article CAS PubMed Google Scholar
• Lobry, C. et al. Notch pathway activation targets AML-initiating cell homeostasis and differentiation. J. Exp. Med. 210, 301–319 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Klinakis, A. et al. A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473, 230–233 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Kode, A. et al. Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts. Nature 506, 240–244 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Dill, M. T. et al. Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of mice. Gastroenterology 142, 967–977 (2012).
  Article CAS PubMed Google Scholar
• Kuhnert, F., Kirshner, J. R. & Thurston, G. Dll4–Notch signaling as a therapeutic target in tumor angiogenesis. Vasc. Cell 3, 20 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Ridgway, J. et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444, 1083–1087 (2006).
  Article CAS PubMed Google Scholar
• Yugawa, T. et al. DeltaNp63alpha repression of the Notch1 gene supports the proliferative capacity of normal human keratinocytes and cervical cancer cells. Cancer Res. 70, 4034–4044 (2010).
  Article CAS PubMed Google Scholar
• Chidgey, M. et al. Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation. J. Cell Biol. 155, 821–832 (2001).
  Article PubMed PubMed Central CAS Google Scholar
• Dumortier, A. et al. Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLoS ONE 5, e9258 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Ezhkova, E. et al. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev. 25, 485–498 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Tan, M. J. et al. Cutaneous beta-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc. Natl Acad. Sci. USA 109, E1473–E1480 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Meyers, J. M., Spangle, J. M. & Munger, K. The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation. J. Virol. 87, 4762–4767 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Aldabagh, B., Angelas, J. G., Cardones, A. R. & Arron, S. T. Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol. Surg. 39, 1–23 (2013).
  Article CAS PubMed Google Scholar
• Connolly, K., Manders, P., Earls, P. & Epstein, R. J. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control. Cancer Treat. Rev. 40, 205–214 (2014).
  Article PubMed Google Scholar
• Lefort, K. et al. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKα kinases. Genes Dev. 21, 562–577 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Parsa, R., Yang, A., McKeon, F. & Green, H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J. Invest. Dermatol. 113, 1099–1105 (1999).
  Article CAS PubMed Google Scholar
• Rocco, J. W., Leong, C. O., Kuperwasser, N., DeYoung, M. P. & Ellisen, L. W. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9, 45–56 (2006).
  Article CAS PubMed Google Scholar
• Keyes, W. M. et al. DeltaNp63alpha is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis. Cell Stem Cell 8, 164–176 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Xu, C. et al. Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression. Cancer Cell 25, 590–604 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Yang, A. et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2, 305–316 (1998).
  Article CAS PubMed Google Scholar
• Senoo, M., Pinto, F., Crum, C. P. & McKeon, F. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129, 523–536 (2007).
  Article CAS PubMed Google Scholar
• Nguyen, B. C. et al. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 20, 1028–1042 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Eferl, R. & Wagner, E. F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859–868 (2003).
  Article CAS PubMed Google Scholar
• Guinea-Viniegra, J. et al. Differentiation-induced skin cancer suppression by FOS, 53, and TACE/ADAM17. J. Clin. Invest. 122, 2898–2910 (2012). The findings of this study demonstrated that FOS and p53 prevented skin cancer development by inducing Notch activity through promoting ADAM17 expression.
  Article PubMed PubMed Central CAS Google Scholar
• Dotto, G. P. Crosstalk of Notch with p53 and p63 in cancer growth control. Nat. Rev. Cancer 9, 587–595 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Kolev, V. et al. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat. Cell Biol. 10, 902–911 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Zanconato, F. et al. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat. Cell Biol. 17, 1218–1227 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Murthy, A. et al. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity 36, 105–119 (2012).
  Article CAS PubMed Google Scholar
• Nowell, C. S. et al. Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction. Nat. Cell Biol. 18, 168–180 (2016). This study revealed how loss of Notch signalling in regenerating epithelia induces aberrant cell fate in stem and progenitor cells indirectly by altering the mechanical properties of the tissue stroma as a consequence of chronic inflammation.
  CAS PubMed Google Scholar
• Demehri, S. et al. Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity. PLoS Biol. 6, e123 (2008). References 95, 114 and 116 all used mouse models to show that many of the pathological consequences of loss of Notch signalling in the epidermis may in part be due to aberrant inflammatory responses in the skin.
  Article PubMed PubMed Central CAS Google Scholar
• Rangarajan, A. et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 20, 3427–3436 (2001).
  Article PubMed PubMed Central CAS Google Scholar
• Restivo, G. et al. IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. EMBO J. 30, 4571–4585 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Vauclair, S. et al. Corneal epithelial cell fate is maintained during repair by Notch1 signaling via the regulation of vitamin A metabolism. Dev. Cell 13, 242–253 (2007).
  Article CAS PubMed Google Scholar
• Collins, C. A. & Watt, F. M. Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for beta-catenin and Notch signalling. Dev. Biol. 324, 55–67 (2008).
  Article CAS PubMed Google Scholar
• Saitou, M. et al. Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature 374, 159–162 (1995).
  Article CAS PubMed Google Scholar
• Syed, Z. et al. All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis. Cancer Prev. Res. 2, 903–911 (2009).
  Article CAS Google Scholar
• Andersen, J. et al. A transcriptional mechanism integrating inputs from extracellular signals to activate hippocampal stem cells. Neuron 83, 1085–1097 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Imayoshi, I. et al. Oscillatory control of factors determining multipotency and fate in mouse neural progenitors. Science 342, 1203–1208 (2013).
  Article CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  CAS PubMed Google Scholar
• Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
  Article PubMed PubMed Central CAS Google Scholar
• Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436–444 (2008).
  Article CAS PubMed Google Scholar
• Demehri, S., Turkoz, A. & Kopan, R. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 16, 55–66 (2009). This work importantly demonstrated a non-cell-autonomous mechanism of Notch-mediated tumour suppression.
  Article PubMed PubMed Central CAS Google Scholar
• Hu, B. et al. Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling. Cell 149, 1207–1220 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Demehri, S. et al. Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin. Cancer Cell 22, 494–505 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Di Piazza, M., Nowell, C. S., Koch, U., Durham, A. D. & Radtke, F. Loss of cutaneous TSLP-dependent immune responses skews the balance of inflammation from tumor protective to tumor promoting. Cancer Cell 22, 479–493 (2012). References 131 and 132 demonstrated how aberrant cytokine activity in Notch-deficient epidermal epithelial cells influenced pro-tumorigenic versus antitumorigenic inflammation in the skin.
  Article CAS PubMed Google Scholar
• Espinosa, L. et al. The Notch/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia. Cancer Cell 18, 268–281 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Coombs, C. C., Tavakkoli, M. & Tallman, M. S. Acute promyelocytic leukemia: where did we start, where are we now, and the future. Blood Cancer J. 5, e304 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Yu, X. M., Phan, T., Patel, P. N., Jaskula-Sztul, R. & Chen, H. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Cancer 119, 774–781 (2013).
  Article CAS PubMed Google Scholar
• Patel, P. N., Yu, X. M., Jaskula-Sztul, R. & Chen, H. Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer. Ann. Surg. Oncol. 21 (Suppl. 4), S497–S504 (2014).
  Article PubMed Google Scholar
• Greenblatt, D. Y. et al. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist 12, 942–951 (2007).
  Article CAS PubMed Google Scholar
• Mohammed, T. A. et al. A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. Oncologist 16, 835–843 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Li, K. et al. Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. J. Biol. Chem. 283, 8046–8054 (2008).
  Article CAS PubMed Google Scholar
• Wu, Y. et al. Therapeutic antibody targeting of individual Notch receptors. Nature 464, 1052–1057 (2010).
  Article CAS PubMed Google Scholar
• Chiu, M. L. & Gilliland, G. L. Engineering antibody therapeutics. Curr. Opin. Struct. Biol. 38, 163–173 (2016).
  Article CAS PubMed Google Scholar
• Auderset, F., Coutaz, M. & Tacchini-Cottier, F. The role of Notch in the differentiation of CD4+ T helper cells. Curr. Top. Microbiol. Immunol. 360, 115–134 (2012).
  CAS PubMed Google Scholar
• Amsen, D. et al. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117, 515–526 (2004).
  Article CAS PubMed Google Scholar
• Amsen, D., Antov, A. & Flavell, R. A. The different faces of Notch in T-helper-cell differentiation. Nat. Rev. Immunol. 9, 116–124 (2009).
  Article CAS PubMed Google Scholar
• Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).
  Article CAS PubMed Google Scholar
• Vinay, D. S. et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin. Cancer Biol. 35, 185–198 (2015).
  Article CAS Google Scholar
• Ellisen, L. W. et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66, 649–661 (1991).
  Article CAS PubMed Google Scholar
• Reynolds, T. C., Smith, S. D. & Sklar, J. Analysis of DNA surrounding the breakpoints of chromosomal translocations involving the beta T cell receptor gene in human lymphoblastic neoplasms. Cell 50, 107–117 (1987).
  Article CAS PubMed Google Scholar
• Capobianco, A. J., Zagouras, P., Blaumueller, C. M., Artavanis-Tsakonas, S. & Bishop, J. M. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol. Cell. Biol. 17, 6265–6273 (1997).
  Article PubMed PubMed Central CAS Google Scholar
• Pear, W. S. et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 183, 2283–2291 (1996).
  Article CAS PubMed Google Scholar
• Weng, A. P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269–271 (2004).
  Article CAS PubMed Google Scholar
• Di Ianni, M. et al. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. Br. J. Haematol. 146, 689–691 (2009).
  Article CAS PubMed Google Scholar
• Fabbri, G. et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J. Exp. Med. 208, 1389–1401 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101–105 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Sportoletti, P. et al. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. Br. J. Haematol. 151, 404–406 (2010).
  Article PubMed Google Scholar
• Kridel, R. et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 119, 1963–1971 (2012).
  Article CAS PubMed Google Scholar
• Rossi, D. et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J. Exp. Med. 209, 1537–1551 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Kiel, M. J. et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J. Exp. Med. 209, 1553–1565 (2012).
  PubMed PubMed Central CAS Google Scholar
• Gallahan, D., Kozak, C. & Callahan, R. A new common integration region (int-3) for mouse mammary tumor virus on mouse chromosome 17. J. Virol. 61, 218–220 (1987).
  PubMed PubMed Central CAS Google Scholar
• Reedijk, M. et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res. 65, 8530–8537 (2005).
  Article CAS PubMed Google Scholar
• Reedijk, M. et al. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res. Treat. 111, 439–448 (2008).
  Article CAS PubMed Google Scholar
• Pece, S. et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J. Cell Biol. 167, 215–221 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Robinson, D. R. et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat. Med. 17, 1646–1651 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Maraver, A. et al. Therapeutic effect of gamma-secretase inhibition in _Kras_G12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK. Cancer Cell 22, 222–234 (2012).
  Article CAS PubMed Google Scholar
• Koch, U. & Radtke, F. Notch signaling in solid tumors. Curr. Top. Dev. Biol. 92, 411–455 (2010).
  Article CAS PubMed Google Scholar
• Ranganathan, P., Weaver, K. L. & Capobianco, A. J. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat. Rev. Cancer 11, 338–351 (2011).
  Article CAS PubMed Google Scholar
• Zender, S. et al. A critical role for notch signaling in the formation of cholangiocellular carcinomas. Cancer Cell 23, 784–795 (2013).
  Article CAS PubMed Google Scholar